Sickle Cell Diseases: Medical Treatments

(asked on 28th August 2020) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when the NICE technology appraisals for upcoming non-malignant haemoglobinopathy therapies will be rescheduled.


Answered by
Nadine Dorries Portrait
Nadine Dorries
This question was answered on 25th September 2020

Two topics for non-malignant haemoglobinopathy therapies were affected by the COVID-19 pause. However, the National Institute for Health and Care Excellence (NICE) is working to reschedule multiple appraisals back into its work programme to recover as quickly as feasibly possible.

Information regarding the current timeline for each appraisal topic is published on the individual topic webpage on the NICE website.

Reticulating Splines